Life Sciences Surgical Instrument Manufacturers sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Life Sciences Surgical Instrument Manufacturers
1.1 - About Life Sciences Surgical Instrument Manufacturers sector
Companies in the Life Sciences Surgical Instrument Manufacturers category design, engineer, and produce reusable and single‑use tools for open and minimally invasive procedures. These vendors deliver precision, reliability, and sterile readiness across specialty lines, helping providers standardize instrument sets and reduce procedural risk. Offerings span general surgery through orthopedic and ophthalmic applications, backed by validated quality systems and compliant supply chains.
They typically provide laparoscopic scissors, graspers, and trocars, electrosurgical handpieces and accessories, forceps, clamps, retractors, scissors, and needle holders, plus stapling and suturing devices. Many offer microsurgical and ophthalmic instruments, orthopedic sets, and specialty trays with instrument tracking. Capabilities include OEM/private‑label design, precision machining, surface finishing, cleaning and passivation, sterilization validation, and ISO 13485 compliant manufacturing with lot traceability and packaging.
Primary customers include hospital and health system ORs, ambulatory surgery centers, and medical device OEMs sourcing branded instruments. Outcomes center on improved surgical precision, faster case turnover, lower infection risk through validated sterility, and cost control via durable reusables and dependable disposable supply. Strategic buyers in surgical instruments also seek portfolio breadth, regulatory compliance, and global distribution to support standardized kits across specialties.
2. Buyers in the Life Sciences Surgical Instrument Manufacturers sector
2.1 Top strategic acquirers of Life Sciences Surgical Instrument Manufacturers companies
Procept BioRobotics
HQ: United States
Website
- Description: Provider of AI-powered surgical robotic systems and heat-free waterjet therapy for urological care; its HYDROS and AQUABEAM platforms perform ultrasound-guided Aquablation therapy to safely and effectively treat benign prostatic hyperplasia (BPH) across all prostate sizes and surgeon skill levels.
- Key Products:
- HYDROS Robotic System: AI-powered robotic platform that automates and delivers Aquablation therapy, using intelligent guidance to remove prostate tissue consistently regardless of gland size or surgeon experience, enhancing safety and outcomes
- AQUABEAM Robotic System: Imaging-integrated robotic device that directs a precise, heat-free waterjet to resect prostate tissue during Aquablation therapy, providing accurate, minimally invasive treatment with durable symptom relief
- Aquablation Therapy: Ultrasound-guided, robotic-assisted, heat-free waterjet procedure that removes obstructive prostate tissue for BPH, offering minimally invasive surgery with consistent, safe and long-lasting results validated by extensive clinical evidence.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Life Sciences Surgical Instrument Manufacturers sector
M&A buyer group 1: Robotic Surgical Instruments
12 companies
View group →
Description: Companies in Medical Robotic Surgical Instrument Systems design, manufacture, and service wristed tools and accessories that interface with robotic surgery platforms. Their products deliver precise articulation, reliable energy delivery, and high-fidelity visualization to enable minimally invasive procedures across specialties. By optimizing instrument performance, lifespan, and compatibility, these vendors help providers improve surgical accuracy, reduce trauma, streamline operating room workflows, and expand the range of robot-assisted interventions.
Brainlab
- Type: N/A
- Employees: ●●●●●
- Description: Provider of digital operating room solutions offering planning & integration, education & training, and comprehensive maintenance support. Brainlab leverages decades of project-management and healthcare IT integration experience to ensure all components—including third-party devices—work seamlessly, helping hospitals optimize clinical workflows and maximize utilization of their digital O.R. investments.
- Key Products:
- Cirq Surgical Robotic Platform: Modular robot-guided system that integrates imaging, navigation and planning to assist minimally invasive spine and cranial procedures with precise instrument positioning and reproducible workflows
- Loop-X Mobile Imaging Robot: Mobile intra- and postoperative imaging robot delivering ergonomic 2D/3D scans with automatic patient registration for accurate navigation during surgery
- Elements Spine Planning software: Advanced planning application providing intuitive 3D visualization, automated segmentation, screw trajectory planning and STL implant integration to enhance precision and efficiency in complex spine cases
- Ultrasound Snap to MRI: Intraoperative tool enabling semi-automated rigid fusion of preoperative MRI with live ultrasound to update registration, improve navigation accuracy and give surgeons real-time anatomical insight.
🔒
🔒
🔒
View all 12 companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms in Life Sciences Surgical Instrument Manufacturers sector
3.1 - Buyout funds in the Life Sciences Surgical Instrument Manufacturers sector
2.2 - Strategic buyer groups for Life Sciences Surgical Instrument Manufacturers sector
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Life Sciences Surgical Instrument Manufacturers companies
4.2 - Public trading comparable groups for Life Sciences Surgical Instrument Manufacturers sector
Valuation benchmark group 1: Surgical Systems and Devices Manufacturers
27 companies
View group →
Description: Companies in this public trading comparables group design, manufacture, and market surgical systems and interventional medical devices across ophthalmology, orthopedics, cardiology, endoscopy, radiation oncology, and robotic-assisted surgery. They sell capital equipment supported by high-margin consumables and service contracts, enabling recurring revenue. Grouped for valuation benchmarks, these device makers share similar regulatory pathways, provider-focused commercial models, and procedure-driven demand profiles that underpin comparable growth and margin dynamics.
Intuitive Surgical
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of robotic-assisted surgical systems and related instruments that enhance the ability of doctors to perform complex surgeries using minimally invasive techniques. Develops, manufactures, and markets the da Vinci Surgical System, offering improved clinical outcomes and greater access to definitive care.
- Key Products:
- da Vinci Surgical System: Robotic-assisted platform that enhances surgeons’ capabilities in performing complex procedures
- EndoWrist Instruments: Surgical instruments designed for use with the da Vinci Surgical System
- E-200 Generator: High-frequency energy generator for cutting, coagulation, and rapid vessel sealing
- Firefly Imaging System: Advanced imaging technology for enhanced visualization during surgery
- Training Programs: Comprehensive training and education services for healthcare providers
🔒
🔒
🔒
View all 27 companies in this group
Request Free Trial Now →
🔒
Revenue growth
Median
15.7%
2025E
16.0%
2026E
EBITDA margin
Median
28.2%
2025E
28.6%
2026E
Cash EBITDA margin
Median
27.6%
2025E
28.0%
2026E
EV/Revenue
Median
8.4x
2025E
6.8x
2026E
EV/EBITDA
Median
28.9x
2025E
24.4x
2026E
EV/Cash EBITDA
Median
29.0x
2025E
25.5x
2026E
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →